MARKET

VOR

VOR

Vor Biopharma Inc.
NASDAQ
0.1600
-0.0125
-7.25%
After Hours: 0.1700 +0.01 +6.25% 19:57 05/13 EDT
OPEN
0.1760
PREV CLOSE
0.1725
HIGH
0.2700
LOW
0.1600
VOLUME
4.72M
TURNOVER
--
52 WEEK HIGH
1.870
52 WEEK LOW
0.1311
MARKET CAP
19.98M
P/E (TTM)
-0.0940
1D
5D
1M
3M
1Y
5Y
1D
Vor Biopharma (VOR) Receives a Buy from Evercore ISI
TipRanks · 23h ago
Weekly Report: what happened at VOR last week (0505-0509)?
Weekly Report · 1d ago
Vor Biopharma draws downgrades on strategic review
Seeking Alpha · 4d ago
Vor Biopharma Cut to Market Perform From Market Outperform by JMP Securities
Dow Jones · 4d ago
Vor Biopharma Price Target Maintained With a $6.00/Share by JMP Securities
Dow Jones · 4d ago
JMP Securities Downgrades Vor Biopharma to Market Perform, Maintains Price Target to $6
Benzinga · 4d ago
VOR BIOPHARMA INC <VOR.O>: STIFEL CUTS TO HOLD FROM BUY; CUTS TARGET PRICE TO $0.3 FROM $5
Reuters · 4d ago
This International Paper Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday
Benzinga · 4d ago
More
About VOR
More
Vor Biopharma Inc. is a clinical-stage cell and genome engineering therapy company. The Company is engaged in combining a novel patient engineering approach with targeted therapies to provide solutions for patients suffering from hematological malignancies. Its proprietary platform leverages expertise in hematopoietic stem cell (HSC) biology, genome engineering and targeted therapy development to genetically modify HSCs to remove surface targets expressed by cancer cells. The Company’s lead engineered hematopoietic stem cells (eHSC) product candidates include tremtelectogene empogeditemcel (trem-cel), for the treatment of acute myeloid leukemia (AML) and other blood cancers. Its VBP101 is a Phase I/II multicenter, open-label, first-in-human study of trem-cel in patients with AML. Its other clinical trial and pipeline products are VCAR33 / VBP301, Trem-cel+VCAR33 Treatment, System CD33-CLL1 Treatment System, and VADC45.
Recently
Symbol
Price
%Change
    VOR
  • 0.1600
  • -7.25%

Webull offers Vor Biopharma Inc stock information, including NASDAQ: VOR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VOR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VOR stock methods without spending real money on the virtual paper trading platform.